ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1028

Probabilistic Linkage of a Cohort of Individuals with Symptoms Suggestive of Early Spondyloarthritis and the French National Healthcare Database

Aya Ajrouche1, Candice Estellat1, Clementina Lopez-Medina2, Anna Molto3, Adeline Ruyssen Witrand4, Pascal Claudepierre5, Florence Tubach6, Laure Gossec7 and Maxime Dougados8, 1AP-HP, Hôpital Pitié-Salpêtrière, Département Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, équipe PEPITES, CIC 1901, F75013, Paris, France, Paris, France, 2Rheumatology Department, Cochin Hospital, Paris, Paris, France, 3Rheumatology Department, Cochin Hospital, APHP, Paris, France, Paris, France, 4Rheumatology center, University Hospital of Toulouse, Inserm 1027, University Paul Sabatier, Toulouse, France, Toulouse, France, 5Hôpital Henri Mondor, Université Paris Est Créteil, EA 7379 EpiDermE, department of rheumatology, Créteil, France, 6Pierre Louis Institute of Epidemiology and Public Health, INSERM 1136, Sorbonne University and Centre of Pharmacoepidemiology, Pitié Salpêtrière Hospital, APHP.Sorbonne University, Paris, Ile-de-France, France, 7Sorbonne Université and Hôpital Universitaire Pitié Salpêtrière, Paris, France, 8Université de Paris, Department of Rheumatology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France

Meeting: ACR Convergence 2020

Keywords: Administrative Data, Epidemiology, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Epidemiology & Public Health Poster III: Inflammatory Rheumatic Disease

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: DESIR is the French cohort of patients with symptoms suggestive of early axial Spondyloarthritis (axSpA). Our objective was to enrich this cohort with claims and hospitalization data from the French national healthcare database (Système National des Données de Santé, SNDS) in order to provide opportunities to answer new research questions related to care consumption, the occurrence of health outcomes and costs and enhance data completeness.

Methods: We carried out a probabilistic linkage of the DESIR cohort database (N=703) and the SNDS (N= 387,463 individuals, sharing the same sex, birth month and year with DESIR  patients). DESIR is a cohort of 708 individuals aged 18 to 60 years, included from 2007 to 2010 in 25 centers in France, of whom 703 were not opposed to this linkage. The probabilistic linkage was performed with the Fellegi and Sunter method, using 29 variables collected between baseline and the 24th month of follow-up. Matching variables included area of residence, attending physician, sacroiliac radiographs and MRI dates, blood test dates and treatment by a Disease Modifying Anti-Rheumatic Drug. We calculated for each DESIR-SNDS potential pair of patients a matching score that summed the matching probabilities calculated across all selected variables. Distributions of the highest matching scores for each DESIR patient and for other matching scores were displayed graphically and a cutoff was chosen visually. Pairs with highest matching score for each individual were matched if they exceed this cutoff. To assess the quality of the linkage we compared individuals’ characteristics between matched and unmatched individuals. P values were computed with T.test, Chi-square test, Wilcoxon test or Fisher exact test.

Results: A total of 594 (84%) were matched. They were, on average, 3 years older than unmatched individuals, were more likely men, and less likely to be HLA-B27 positive. No significant difference was observed between matched and unmatched on baseline clinical or radiographic characteristics: BASDAI and BASFI scores, MRI sacroiliac joint inflammation (ASAS criteria) neither among anti-TNF treatment during the first 5 years of follow-up. Finally, rate of loss to follow up by year 5 were similar in both groups while rate of exit from the DESIR cohort due to other diagnosis than axSpA was slightly higher but not significantly so, among matched vs. unmatched.

Conclusion: It was possible to perform a matching for 84% of patients. No difference was observed on clinical or radiographic characteristics nor treatment between matched and unmatched individuals, thus this cohort issued from the linkage can be used to study outcomes among patients with symptoms suggestive of early axSpA. A possible bias related to both male, older and HLA-B27 positivity over-representation should be discussed in any future study using this linked cohort. In a next step, a deterministic linkage will be performed using a unique individual identifier to validate this linkage and capture remaining unmatched individuals. 


Disclosure: A. Ajrouche, None; C. Estellat, None; C. Lopez-Medina, None; A. Molto, ABBVIE, 5, BMS, 5, 8, LILLY, 5, NOVARTIS, 5, 8, UCB, 5, 8, GILEAD, 5; A. Ruyssen Witrand, None; P. Claudepierre, Abbvie, 5, 8, Pfizer, 5, 8, UCB, 5, 8, Merk, 5, 8, novartis, 5, 8, Lilly, 5, 8, Janssen, 5, 8, BMS, 5, 8; F. Tubach, None; L. Gossec, Sandoz, 1, AbbVie, 5, 8, Amgen Inc., 5, 8, Biogen, 5, 8, Janssen, 5, 8, Celgene, 5, 8, Eli Lilly, 1, 5, 8, Novartis, 5, 8, Pfizer, 1, 5, 8, UCB Pharma, 5, 8, Sanofi, 5, 8; M. Dougados, Pfizer, 5, 8, AbbVie, 5, 8, Roche, 5, 8, Bristol-Myers Squibb, 5, 8, Eli Lilly, 5, 8, Novartis, 5, 8, Sanofi, 5, 8, Biogen, 5, 8, Merck Sharp & Dohme, 5, 8, UCB Pharma, 5, 8.

To cite this abstract in AMA style:

Ajrouche A, Estellat C, Lopez-Medina C, Molto A, Ruyssen Witrand A, Claudepierre P, Tubach F, Gossec L, Dougados M. Probabilistic Linkage of a Cohort of Individuals with Symptoms Suggestive of Early Spondyloarthritis and the French National Healthcare Database [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/probabilistic-linkage-of-a-cohort-of-individuals-with-symptoms-suggestive-of-early-spondyloarthritis-and-the-french-national-healthcare-database/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/probabilistic-linkage-of-a-cohort-of-individuals-with-symptoms-suggestive-of-early-spondyloarthritis-and-the-french-national-healthcare-database/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology